Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 2892840, 10 pages
http://dx.doi.org/10.1155/2016/2892840
Review Article

Mesenchymal Stem Cells and Metabolic Syndrome: Current Understanding and Potential Clinical Implications

Division of Cardiology, Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo 181-8611, Japan

Received 6 February 2016; Revised 6 April 2016; Accepted 4 May 2016

Academic Editor: Paulo J. Oliveira

Copyright © 2016 Kenichi Matsushita. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” The Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. K. G. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Haffner and H. Taegtmeyer, “Epidemic obesity and the metabolic syndrome,” Circulation, vol. 108, no. 13, pp. 1541–1545, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. R. H. Lee, B. Kim, I. Choi et al., “Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue,” Cellular Physiology and Biochemistry, vol. 14, no. 4–6, pp. 311–324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D.-C. Ding, Y.-H. Chang, W.-C. Shyu, and S.-Z. Lin, “Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy,” Cell Transplantation, vol. 24, no. 3, pp. 339–347, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Mutlu, D. Hufnagel, and H. S. Taylor, “The endometrium as a source of mesenchymal stem cells for regenerative medicine,” Biology of Reproduction, vol. 92, no. 6, article 138, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. W. M. Jackson, L. J. Nesti, and R. S. Tuan, “Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells,” Expert Opinion on Biological Therapy, vol. 10, no. 4, pp. 505–517, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Davani, L. Ikonomou, B. M. Raaka et al., “Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo,” Stem Cells, vol. 25, no. 12, pp. 3215–3222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Pan, S. M. G. Fouraschen, F. S. F. A. Kaya et al., “Mobilization of hepatic mesenchymal stem cells from human liver grafts,” Liver Transplantation, vol. 17, no. 5, pp. 596–609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. E. Bernardo, D. Pagliara, and F. Locatelli, “Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine,” Bone Marrow Transplantation, vol. 47, no. 2, pp. 164–171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. N. El-Badri and M. A. Ghoneim, “Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges,” Journal of Nucleic Acids, vol. 2013, Article ID 194858, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. E. Marketou, F. I. Parthenakis, A. Kalyva et al., “Increased mobilization of mesenchymal stem cells in patients with essential hypertension: the effect of left ventricular hypertrophy,” Journal of Clinical Hypertension, vol. 16, no. 12, pp. 883–888, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Shen, E. Zhou, X. Wei et al., “High density lipoprotein promotes proliferation of adipose-derived stem cells via S1P1 receptor and Akt, ERK1/2 signal pathways,” Stem Cell Research & Therapy, vol. 6, no. 1, article 95, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Tolar, K. Le Blanc, A. Keating, and B. R. Blazar, “Concise review: hitting the right spot with mesenchymal stromal cells,” Stem Cells, vol. 28, no. 8, pp. 1446–1455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. W. James, “Review of signaling pathways governing MSC osteogenic and adipogenic differentiation,” Scientifica, vol. 2013, Article ID 684736, 17 pages, 2013. View at Publisher · View at Google Scholar
  17. S. Muruganandan, A. A. Roman, and C. J. Sinal, “Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program,” Cellular and Molecular Life Sciences, vol. 66, no. 2, pp. 236–253, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. E. D. Rosen and O. A. MacDougald, “Adipocyte differentiation from the inside out,” Nature Reviews: Molecular Cell Biology, vol. 7, no. 12, pp. 885–896, 2006. View at Publisher · View at Google Scholar
  19. M. I. Lefterova and M. A. Lazar, “New developments in adipogenesis,” Trends in Endocrinology and Metabolism, vol. 20, no. 3, pp. 107–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. E. D. Rosen, C. J. Walkey, P. Puigserver, and B. M. Spiegelman, “Transcriptional regulation of adipogenesis,” Genes and Development, vol. 14, no. 11, pp. 1293–1307, 2000. View at Google Scholar · View at Scopus
  21. L. A. Davis and N. I. Zur Nieden, “Mesodermal fate decisions of a stem cell: the Wnt switch,” Cellular and Molecular Life Sciences, vol. 65, no. 17, pp. 2658–2674, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. N. K. Satija, G. U. Gurudutta, S. Sharma et al., “Mesenchymal stem cells: molecular targets for tissue engineering,” Stem Cells and Development, vol. 16, no. 1, pp. 7–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. N. Bennett, S. E. Ross, K. A. Longo et al., “Regulation of Wnt signaling during adipogenesis,” The Journal of Biological Chemistry, vol. 277, no. 34, pp. 30998–31004, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. E. Ross, N. Hemati, K. A. Longo et al., “Inhibition of adipogenesis by Wnt signaling,” Science, vol. 289, no. 5481, pp. 950–953, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Christodoulides, M. Laudes, W. P. Cawthorn et al., “The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis,” Journal of Cell Science, vol. 119, no. 12, pp. 2613–2620, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. K. A. Longo, W. S. Wright, S. Kang et al., “Wnt10b inhibits development of white and brown adipose tissues,” The Journal of Biological Chemistry, vol. 279, no. 34, pp. 35503–35509, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. W. S. Wright, K. A. Longo, V. W. Dolinsky et al., “Wnt10b inhibits obesity in ob/ob and agouti mice,” Diabetes, vol. 56, no. 2, pp. 295–303, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Fontaine, W. Cousin, M. Plaisant, C. Dani, and P. Peraldi, “Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells,” Stem Cells, vol. 26, no. 4, pp. 1037–1046, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. W. James, A. Pan, M. Chiang et al., “A new function of Nell-1 protein in repressing adipogenic differentiation,” Biochemical and Biophysical Research Communications, vol. 411, no. 1, pp. 126–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. W. James, S. Pang, A. Askarinam et al., “Additive effects of sonic hedgehog and nell-1 signaling in osteogenic versus adipogenic differentiation of human adipose-derived stromal cells,” Stem Cells and Development, vol. 21, no. 12, pp. 2170–2178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Ng, S. Boucher, S. Koh et al., “PDGF, tgf- 2. And FGF signaling is important for differentiation and growth of mesenchymal stem cells (mscs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages,” Blood, vol. 112, no. 2, pp. 295–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. B. A. J. Roelen and P. ten Dijke, “Controlling mesenchymal stem cell differentiation by TGFβ family members,” Journal of Orthopaedic Science, vol. 8, no. 5, pp. 740–748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. R. R. Bowers, J. W. Kim, T. C. Otto, and M. D. Lane, “Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 35, pp. 13022–13027, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. R. R. Bowers and M. D. Lane, “A role for bone morphogenetic protein-4 in adipocyte development,” Cell Cycle, vol. 6, no. 4, pp. 385–389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Holzenberger, G. Hamard, R. Zaoui et al., “Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular,” Endocrinology, vol. 142, no. 10, pp. 4469–4478, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Jia and J. N. M. Heersche, “Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone,” Bone, vol. 27, no. 6, pp. 785–794, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. Q. Kang, W.-X. Song, Q. Luo et al., “A Comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells,” Stem Cells and Development, vol. 18, no. 4, pp. 545–558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. L. M. Scavo, M. Karas, M. Murray, and D. Leroith, “Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 7, pp. 3543–3553, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. C. G. Brook, J. K. Lloyd, and O. H. Wolf, “Relation between age of onset of obesity and size and number of adipose cells,” British Medical Journal, vol. 2, no. 5804, pp. 25–27, 1972. View at Publisher · View at Google Scholar · View at Scopus
  40. I. M. Faust, P. R. Johnson, J. S. Stern, and J. Hirsch, “Diet-induced adipocyte number increase in adult rats: a new model of obesity,” The American Journal of Physiology, vol. 235, no. 3, pp. E279–E286, 1978. View at Google Scholar · View at Scopus
  41. J. Hirsch and B. Batchelor, “Adipose tissue cellularity in human obesity,” Clinics in Endocrinology and Metabolism, vol. 5, no. 2, pp. 299–311, 1976. View at Publisher · View at Google Scholar · View at Scopus
  42. B. W. Phillips, C. Vernochet, and C. Dani, “Differentiation of embryonic stem cells for pharmacological studies on adipose cells,” Pharmacological Research, vol. 47, no. 4, pp. 263–268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. P. A. Zuk, M. Zhu, H. Mizuno et al., “Multilineage cells from human adipose tissue: implications for cell-based therapies,” Tissue Engineering, vol. 7, no. 2, pp. 211–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. D. A. De Ugarte, K. Morizono, A. Elbarbary et al., “Comparison of multi-lineage cells from human adipose tissue and bone marrow,” Cells Tissues Organs, vol. 174, no. 3, pp. 101–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. K. W. Liechty, T. C. Mackenzie, A. F. Shaaban et al., “Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep,” Nature Medicine, vol. 6, no. 11, pp. 1282–1286, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. J. T. Crossno Jr., S. M. Majka, T. Grazia, R. G. Gill, and D. J. Klemm, “Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells,” The Journal of Clinical Investigation, vol. 116, no. 12, pp. 3220–3228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Bost, M. Aouadi, L. Caron, and B. Binétruy, “The role of MAPKs in adipocyte differentiation and obesity,” Biochimie, vol. 87, no. 1, pp. 51–56, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. D. B. Hausman, M. DiGirolamo, T. J. Bartness, G. J. Hausman, and R. J. Martin, “The biology of white adipocyte proliferation,” Obesity Reviews, vol. 2, no. 4, pp. 239–254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. C. T. Rubin, E. Capilla, Y. K. Luu et al., “Adipogenesis is inhibited by brief, daily exposure to high-frequency, extremely low-magnitude mechanical signals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 45, pp. 17879–17884, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. J. A. Batsis, M. G. Sarr, M. L. Collazo-Clavell et al., “Cardiovascular risk after bariatric surgery for obesity,” American Journal of Cardiology, vol. 102, no. 7, pp. 930–937, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. H. M. Heneghan, S. Meron-Eldar, S. A. Brethauer, P. R. Schauer, and J. B. Young, “Effect of bariatric surgery on cardiovascular risk profile,” American Journal of Cardiology, vol. 108, no. 10, pp. 1499–1507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Sjöström, A.-K. Lindroos, M. Peltonen et al., “Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery,” The New England Journal of Medicine, vol. 351, no. 26, pp. 2683–2693, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Torquati, K. Wright, W. Melvin, and W. Richards, “Effect of gastric bypass operation on framingham and actual risk of cardiovascular events in class II to III obesity,” Journal of the American College of Surgeons, vol. 204, no. 5, pp. 776–782, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. J.-G. Chen, A. Spagnoli, and A. Torquati, “Adipogenic differentiation of adipose tissue-derived human mesenchymal stem cells: effect of gastric bypass surgery,” Surgical Endoscopy, vol. 26, no. 12, pp. 3449–3456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Jakobsson, E. Treuter, J.-Å. Gustafsson, and K. R. Steffensen, “Liver X receptor biology and pharmacology: new pathways, challenges and opportunities,” Trends in Pharmacological Sciences, vol. 33, no. 7, pp. 394–404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. B. A. Janowski, P. J. Willy, T. R. Devi, J. R. Falck, and D. J. Mangelsdorf, “An oxysterol signalling pathway mediated by the nuclear receptor LXRα,” Nature, vol. 383, no. 6602, pp. 728–731, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Kidani and S. J. Bensinger, “Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity,” Immunological Reviews, vol. 249, no. 1, pp. 72–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Parikh, K. Patel, S. Soni, and T. Gandhi, “Liver X receptor: a cardinal target for atherosclerosis and beyond,” Journal of Atherosclerosis and Thrombosis, vol. 21, no. 6, pp. 519–531, 2014. View at Google Scholar · View at Scopus
  59. D. J. Peet, S. D. Turley, W. Ma et al., “Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα,” Cell, vol. 93, no. 5, pp. 693–704, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. K. R. Steffensen and J.-Å. Gustafsson, “Putative metabolic effects of the liver X receptor (LXR),” Diabetes, vol. 53, supplement 1, pp. S36–S42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. K. A. Tobin, H. H. Steineger, S. Albert et al., “Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-α,” Molecular Endocrinology, vol. 14, no. 5, pp. 741–752, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Venkateswaran, B. A. Laffitte, S. B. Joseph et al., “Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 22, pp. 12097–12102, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Zelcer and P. Tontonoz, “Liver X receptors as integrators of metabolic and inflammatory signaling,” The Journal of Clinical Investigation, vol. 116, no. 3, pp. 607–614, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Gao and D. Liu, “The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance,” AAPS Journal, vol. 15, no. 1, pp. 258–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. L. K. Juvet, S. M. Andresen, G. U. Schuster et al., “On the role of liver X receptors in lipid accumulation in adipocytes,” Molecular Endocrinology, vol. 17, no. 2, pp. 172–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. S. E. Ross, R. L. Erickson, I. Gerin et al., “Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor α in adipocyte metabolism,” Molecular and Cellular Biology, vol. 22, no. 16, pp. 5989–5999, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. K. R. Steffensen, G. U. Schuster, P. Parini et al., “Different regulation of the LXRAα promoter activity by isoforms of CCAAT/enhancer-binding proteins,” Biochemical and Biophysical Research Communications, vol. 293, no. 5, pp. 1333–1340, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. P. J. Willy, K. Umesono, E. S. Ong, R. M. Evans, R. A. Heyman, and D. J. Mangelsdorf, “LXR, a nuclear receptor that defines a distinct retinoid response pathway,” Genes and Development, vol. 9, no. 9, pp. 1033–1045, 1995. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Soukas, N. D. Socci, B. D. Saatkamp, S. Novelli, and J. M. Friedman, “Distinct transcriptional profiles of adipogenesis in vivo and in vitro,” The Journal of Biological Chemistry, vol. 276, no. 36, pp. 34167–34174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Matsushita, F. Morello, Z. Zhang et al., “Nuclear hormone receptor LXRα inhibits adipocyte differentiation of mesenchymal stem cells with Wnt/beta-catenin signaling,” Laboratory Investigation, vol. 96, no. 2, pp. 230–238, 2016. View at Publisher · View at Google Scholar
  71. S. W. Beaven, A. Matveyenko, K. Wroblewski et al., “Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance,” Cell Metabolism, vol. 18, no. 1, pp. 106–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. N. Y. Kalaany, K. C. Gauthier, A. M. Zavacki et al., “LXRs regulate the balance between fat storage and oxidation,” Cell Metabolism, vol. 1, no. 4, pp. 231–244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Matsushita, Y. Wu, Y. Okamoto, R. E. Pratt, and V. J. Dzau, “Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes,” Hypertension, vol. 48, no. 6, pp. 1095–1102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. K. Matsushita, Y. Wu, R. E. Pratt, and V. J. Dzau, “Blockade of angiotensin II type 2 receptor by PD123319 inhibits osteogenic differentiation of human mesenchymal stem cells via inhibition of extracellular signal-regulated kinase signaling,” Journal of the American Society of Hypertension, vol. 9, no. 7, pp. 517–525, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Matsushita, F. Morello, Y. Wu et al., “Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-α,” The Journal of Biological Chemistry, vol. 285, no. 16, pp. 11974–11982, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Matsushita, Z. Zhang, R. E. Pratt, and V. J. Dzau, “Molecular mechanism of juxtaglomerular cell hyperplasia: a unifying hypothesis,” Journal of the American Society of Hypertension, vol. 1, no. 3, pp. 164–168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Darimont, G. Vassaux, G. Ailhaud, and R. Negrel, “Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II,” Endocrinology, vol. 135, no. 5, pp. 2030–2036, 1994. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Saint-Marc, L. P. Kozak, G. Ailhaud, C. Darimontt, and R. Negrel, “Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation,” Endocrinology, vol. 142, no. 1, pp. 487–492, 2001. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Schling and G. Löffler, “Effects of angiotensin II on adipose conversion and expression of genes of the renin-angiotensin system in human preadipocytes,” Hormone and Metabolic Research, vol. 33, no. 4, pp. 189–195, 2001. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Janke, S. Engeli, K. Gorzelniak, F. C. Luft, and A. M. Sharma, “Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors,” Diabetes, vol. 51, no. 6, pp. 1699–1707, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. L. F. de Oliveira, T. R. Almeida, M. P. R. Machado et al., “Priming mesenchymal stem cells with endothelial growth medium boosts stem cell therapy for systemic arterial hypertension,” Stem Cells International, vol. 2015, Article ID 685383, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. M. McIntyre, D. F. Bohr, and A. F. Dominiczak, “Endothelial function in hypertension: the role of superoxide anion,” Hypertension, vol. 34, no. 4, part 1, pp. 539–545, 1999. View at Publisher · View at Google Scholar · View at Scopus
  83. R. M. Touyz, “Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?” Hypertension, vol. 44, no. 3, pp. 248–252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. M. E. Marketou and P. E. Vardas, “Stem cells and hypertension: another challenge for the future?” Hellenic Journal of Cardiology, vol. 52, no. 4, pp. 289–292, 2011. View at Google Scholar · View at Scopus
  85. R. H. Eckel, S. E. Kahn, E. Ferrannini et al., “Obesity and type 2 diabetes: what can be unified and what needs to be individualized?” Diabetes Care, vol. 34, no. 6, pp. 1424–1430, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. V. Chandra, S. G, S. Phadnis, P. D. Nair, and R. R. Bhonde, “Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells,” STEM CELLS, vol. 27, no. 8, pp. 1941–1953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. D. Marappagounder, I. Somasundaram, S. Dorairaj, and R. J. Sankaran, “Differentiation of mesenchymal stem cells derived from human bone marrow and subcutaneous adipose tissue into pancreatic islet-like clusters in vitro,” Cellular & Molecular Biology Letters, vol. 18, no. 1, pp. 75–88, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. S. D. Dave, A. V. Vanikar, and H. L. Trivedi, “Ex vivo generation of glucose sensitive insulin secreting mesenchymal stem cells derived from human adipose tissue,” Indian Journal of Endocrinology and Metabolism, vol. 16, Supplement 1, pp. S65–S69, 2012. View at Publisher · View at Google Scholar
  89. M. Dhanasekaran, S. Indumathi, R. Harikrishnan et al., “Human omentum fat-derived mesenchymal stem cells transdifferentiates into pancreatic islet-like cluster,” Cell Biochemistry and Function, vol. 31, no. 7, pp. 612–619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. P. R. Moshtagh, S. H. Emami, and A. M. Sharifi, “Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study,” Journal of Physiology and Biochemistry, vol. 69, no. 3, pp. 451–458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. K. Timper, D. Seboek, M. Eberhardt et al., “Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells,” Biochemical and Biophysical Research Communications, vol. 341, no. 4, pp. 1135–1140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Ohmura, M. Tanemura, N. Kawaguchi et al., “Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice,” Transplantation, vol. 90, no. 12, pp. 1366–1373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. Y. Fumimoto, A. Matsuyama, H. Komoda et al., “Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice,” Tissue Engineering Part C: Methods, vol. 15, no. 3, pp. 437–444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. Y.-Y. Li, H.-H. Liu, H.-L. Chen, and Y.-P. Li, “Adipose-derived mesenchymal stem cells ameliorate STZ-induced pancreas damage in type 1 diabetes,” Bio-Medical Materials and Engineering, vol. 22, no. 1–3, pp. 97–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Cao, Q. Pan, H. Dong et al., “Adipose-derived mesenchymal stem cells improve glucose homeostasis in high-fat diet-induced obese mice,” Stem Cell Research & Therapy, vol. 6, article 208, 2015. View at Publisher · View at Google Scholar · View at Scopus
  96. S. D. Dave, A. V. Vanikar, H. L. Trivedi, U. G. Thakkar, S. C. Gopal, and T. Chandra, “Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells,” Clinical and experimental medicine, vol. 15, no. 1, pp. 41–45, 2015. View at Publisher · View at Google Scholar · View at Scopus
  97. G. Egger, G. Liang, A. Aparicio, and P. A. Jones, “Epigenetics in human disease and prospects for epigenetic therapy,” Nature, vol. 429, no. 6990, pp. 457–463, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. E. R. Gibney and C. M. Nolan, “Epigenetics and gene expression,” Heredity, vol. 105, no. 1, pp. 4–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Sato, S. Tsuchiya, S. J. Meltzer, and K. Shimizu, “MicroRNAs and epigenetics,” The FEBS Journal, vol. 278, no. 10, pp. 1598–1609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. C. Shi, M. Zhang, M. Tong et al., “MiR-148a is associated with obesity and modulates adipocyte differentiation of mesenchymal stem cells through wnt signaling,” Scientific Reports, vol. 5, article 9930, 2015. View at Publisher · View at Google Scholar · View at Scopus
  101. L. Wang, L. Xu, M. Xu et al., “Obesity-associated MiR-342-3p promotes adipogenesis of mesenchymal stem cells by suppressing CtBP2 and releasing C/EBPα from CtBP2 binding,” Cellular Physiology and Biochemistry, vol. 35, no. 6, pp. 2285–2298, 2015. View at Publisher · View at Google Scholar · View at Scopus
  102. K. E. Boyle, Z. W. Patinkin, A. L. Shapiro, P. R. Baker II, D. Dabelea, and J. E. Friedman, “Mesenchymal stem cells from infants born to obese mothers exhibit greater potential for adipogenesis: the healthy start BabyBUMP project,” Diabetes, vol. 65, no. 3, pp. 647–659, 2016. View at Publisher · View at Google Scholar
  103. J. Moitra, M. M. Mason, M. Olive et al., “Life without white fat: a transgenic mouse,” Genes & Development, vol. 12, no. 20, pp. 3168–3181, 1998. View at Publisher · View at Google Scholar · View at Scopus
  104. K. Cusi, “The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes,” Current Diabetes Reports, vol. 10, no. 4, pp. 306–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. S. Hocking, D. Samocha-Bonet, K.-L. Milner, J. R. Greenfield, and D. J. Chisholm, “Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots,” Endocrine Reviews, vol. 34, no. 4, pp. 463–500, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Lim, “Ectopic fat assessment focusing on cardiometabolic and renal risk,” Endocrinology and Metabolism, vol. 29, no. 1, pp. 1–4, 2014. View at Publisher · View at Google Scholar
  107. X. Ma, P. Lee, D. J. Chisholm, and D. E. James, “Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy,” Frontiers in Endocrinology, vol. 6, article 1, Article ID 00001, 2015. View at Publisher · View at Google Scholar · View at Scopus
  108. N. Sattar and J. M. R. Gill, “Type 2 diabetes as a disease of ectopic fat?” BMC Medicine, vol. 12, no. 1, article 123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Jacob, J. Machann, K. Rett et al., “Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects,” Diabetes, vol. 48, no. 5, pp. 1113–1119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  110. S. Lim and J. B. Meigs, “Links between ectopic fat and vascular disease in humans,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 9, pp. 1820–1826, 2014. View at Publisher · View at Google Scholar · View at Scopus
  111. D. I. W. Phillips, S. Caddy, V. Ilic et al., “Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects,” Metabolism: Clinical and Experimental, vol. 45, no. 8, pp. 947–950, 1996. View at Publisher · View at Google Scholar · View at Scopus
  112. T. Galbo and G. I. Shulman, “Lipid-induced hepatic insulin resistance,” Aging, vol. 5, no. 8, pp. 582–583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Heni, J. Machann, H. Staiger et al., “Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 3, pp. 200–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. L. S. Szczepaniak, R. G. Victor, R. Mathur et al., “Pancreatic steatosis and its relationship to β-cell dysfunction in humans: racial and ethnic variations,” Diabetes Care, vol. 35, no. 11, pp. 2377–2383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. M. E. Tushuizen, M. C. Bunck, P. J. Pouwels et al., “Pancreatic fat content and beta-cell function in men with and without type 2 diabetes,” Diabetes Care, vol. 30, no. 11, pp. 2916–2921, 2007. View at Publisher · View at Google Scholar
  116. L. da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, “Mesenchymal stem cells reside in virtually all post-natal organs and tissues,” Journal of Cell Science, vol. 119, no. 11, pp. 2204–2213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. A. Uezumi, S.-I. Fukada, N. Yamamoto, S. Takeda, and K. Tsuchida, “Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle,” Nature Cell Biology, vol. 12, no. 2, pp. 143–152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. A. Okuno, H. Tamemoto, K. Tobe et al., “Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats,” Journal of Clinical Investigation, vol. 101, no. 6, pp. 1354–1361, 1998. View at Publisher · View at Google Scholar · View at Scopus
  119. J. Rieusset, F. Touri, L. Michalik et al., “A new selective peroxisome proliferator-activated receptor γ antagonist with antiobesity and antidiabetic activity,” Molecular Endocrinology, vol. 16, no. 11, pp. 2628–2644, 2002. View at Publisher · View at Google Scholar · View at Scopus
  120. J. R. Jones, C. Barrick, K.-A. Kim et al., “Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 17, pp. 6207–6212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  121. P. D. G. Miles, Y. Barak, W. He, R. M. Evans, and J. M. Olefsky, “Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency,” Journal of Clinical Investigation, vol. 105, no. 3, pp. 287–292, 2000. View at Publisher · View at Google Scholar · View at Scopus
  122. J. M. Olefsky, “Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 467–472, 2000. View at Publisher · View at Google Scholar · View at Scopus
  123. B. M. Spiegelman, “PPAR-γ: adipogenic regulator and thiazolidinedione receptor,” Diabetes, vol. 47, no. 4, pp. 507–514, 1998. View at Publisher · View at Google Scholar · View at Scopus
  124. T. Yamauchi, J. Kamon, H. Waki et al., “The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARγ) deficiency and PPARγ agonist improve insulin resistance,” The Journal of Biological Chemistry, vol. 276, no. 44, pp. 41245–41254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  125. R. E. Soccio, E. R. Chen, and M. A. Lazar, “Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes,” Cell Metabolism, vol. 20, no. 4, pp. 573–591, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. J. Fu, Z. Li, H. Zhang et al., “Molecular pathways regulating the formation of brown-like adipocytes in white adipose tissue,” Diabetes/Metabolism Research and Reviews, vol. 31, no. 5, pp. 433–452, 2015. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Roman, A. Agil, M. Peran et al., “Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders,” Translational Research, vol. 165, no. 4, pp. 464–479, 2015. View at Publisher · View at Google Scholar · View at Scopus
  128. S. Enerbäck, A. Jacobsson, E. M. Simpson et al., “Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese,” Nature, vol. 387, no. 6628, pp. 90–94, 1997. View at Publisher · View at Google Scholar · View at Scopus
  129. J. Kopecky, G. Clarke, S. Enerbäck, B. Spiegelman, and L. P. Kozak, “Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity,” Journal of Clinical Investigation, vol. 96, no. 6, pp. 2914–2923, 1995. View at Publisher · View at Google Scholar · View at Scopus
  130. L. P. Kozak and R. Anunciado-Koza, “UCP1: its involvement and utility in obesity,” International Journal of Obesity, vol. 32, supplement 7, pp. S32–S38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. A.-L. Poher, J. Altirriba, C. Veyrat-Durebex, and F. Rohner-Jeanrenaud, “Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance,” Frontiers in Physiology, vol. 6, article 004, 2015. View at Publisher · View at Google Scholar · View at Scopus
  132. V. García-Alonso and J. Clària, “Prostaglandin E2 signals white-to-brown adipogenic differentiation,” Adipocyte, vol. 3, no. 4, pp. 290–296, 2014. View at Publisher · View at Google Scholar
  133. V. García-Alonso, C. López-Vicario, E. Titos et al., “Coordinate functional regulation between microsomal prostaglandin e synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor γ (PPARγ) in the conversion of white-to-brown adipocytes,” The Journal of Biological Chemistry, vol. 288, no. 39, pp. 28230–28242, 2013. View at Publisher · View at Google Scholar · View at Scopus